Peptides against cancer (L-11627/11964) . : NR16-174/2017E-PDF
“NRC has developed peptides with novel anti-angiogenic properties that are effective against many different stimulators of angiogenesis. The NRC peptides exhibit direct anti-tumorogenic properties against different types of tumors and have been validated in vivo. The antiangiogenic activity against multiple stimulators, combined with the direct inhibition of tumour growth, position these peptides as promising treatments against malignant tumours”--Highlights.
Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.847576&sl=1
| Ministère/Organisme | National Research Council Canada. |
|---|---|
| Titre | Peptides against cancer (L-11627/11964) . |
| Type de publication | Monographie |
| Langue | [Anglais] |
| Autres langues publiées | [Français] |
| Format | Électronique |
| Document électronique | |
| Note(s) | Issued also in French under title: Peptides contre le cancer (L-11627/11964). Caption title. "December 2017." Issued also in print format. |
| Information sur la publication | [Ottawa] : National Research Council Canada, [2018] |
| Description | [1] p. |
| ISBN | 9780660239583 |
| Numéro de catalogue |
|
| Descripteurs | Neovascularization inhibitors Peptides |
Demander des formats alternatifs
Pour demander une publication dans un format alternatif, remplissez le formulaire électronique des publications du gouvernement du Canada. Utilisez le champ du formulaire «question ou commentaire» pour spécifier la publication demandée.- Date de modification :